Everything you need, all in one place

 

This is your Novartis hub, newly designed to provide you, the healthcare professional, with everything you need to support you and your patients. On NovartisPro Ireland you will find all of the existing content with the addition, in some instances, of new and updated content.

NovartisPro Ireland contains the latest product information, resources and training materials, alongside events, webinars, formulary and service support. Everything you need to help you deliver excellent care for your patients.

 

Medical information:

 

+353 1 260 1255

[email protected]

logo-cosentyx-product-card
Dermatology
COSENTYX® (secukinumab)
logo-kisqali-product-card
Oncology
KISQALI® (ribociclib)
Kesimpta logo.
Neuroscience
KESIMPTA®▼(ofatumumab)
Leqvio logo.
Cardiology
LEQVIO® (inclisiran)
logo-cosentyx-product-card
Rheumatology
COSENTYX® (secukinumab)
logo-entresto-product-card
Cardiology
ENTRESTO® (sacubitril/valsartan)

September 2025 | IE11499091

Reporting of side effects:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.